Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von David J Hirst und 41 weiteren Autor:innen. Beteiligte Einrichtung: GSK Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, U.K. Hauptthemen laut MEDLINE: Administration, Intravenous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
The bromodomain and extra terminal (BET) family of bromodomain-containing proteins are important epigenetic regulators that elicit their effect through binding histone tail N-acetyl lysine (KAc) post-translational modifications. Recognition of such markers has been implicated in a range of oncology and immune diseases and, as such, small-molecule inhibition of the BET family bromodomain-KAc protein-protein interaction has received significant interest as a therapeutic strategy, with several potential medicines under clinical evaluation. This work describes the structure- and property-based optimization of a ligand and lipophilic efficient pan-BET bromodomain inhibitor series to deliver candidate I-BET787 (70) that demonstrates efficacy in a mouse model of inflammation and suitable properties for both oral and intravenous (IV) administration. This focused two-phase explore-exploit medicinal chemistry effort delivered the candidate molecule in 3 months with less than 100 final compounds synthesized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GSK Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, U.K.
ORCID-Profile: Paul Bamborough, Chun-Wa Chung, Katherine L Jones, Darren L Poole, Christopher R Wellaway, Philip G Humphreys
Zitieren
APA
Hirst, D. J., Bamborough, P., Al-Mahdi, N., Angell, D. C., Barnett, H. A., Baxter, A., Bit, R. A., Brown, J. A., Chung, C. W., Craggs, P. D., Davis, R. P., Demont, E. H., Ferrie, A., Gordon, L. J., Harada, I., Ho, T. C. T., Holyer, I. D., Hooper-Greenhill, E., Jones, K. L., …, & Humphreys, P. G. (2024). Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00959
Vancouver
Hirst DJ, Bamborough P, Al-Mahdi N, Angell DC, Barnett HA, Baxter A, et al. Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00959
BibTeX
@article{Hirst2024,
author = {Hirst, David J and Bamborough, Paul and Al-Mahdi, Niam and Angell, Davina C and Barnett, Heather A and Baxter, Andrew and Bit, Rino A and Brown, Jack A and Chung, Chun-Wa and Craggs, Peter D and Davis, Robert P and Demont, Emmanuel H and Ferrie, Alan and Gordon, Laurie J and Harada, Isobel and Ho, Tim C T and Holyer, Ian D and Hooper-Greenhill, Edward and Jones, Katherine L and Lindon, Matthew J and Lovatt, Cerys and Lugo, David and Maller, Claire and McGonagle, Grant and Messenger, Cassie and Mitchell, Darren J and Pascoe, David D and Patel, Vipulkumar K and Patten, Christopher and Poole, Darren L and Shah, Rishi R and Rioja, Inmaculada and Stafford, Kayleigh A J and Tape, Daniel and Taylor, Simon and Theodoulou, Natalie H and Tomlinson, Laura and Wall, Ian D and Wellaway, Christopher R and White, Gemma and Prinjha, Rab K and Humphreys, Philip G},
title = {Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00959}
}
EUVIMED